V

Vaxxinity

88 employees

Vaxxinity is a biotechnology company that enables the innovation of synthetic peptide vaccines to prevent or treat infectious diseases.

Basic info

biotechnology research

Pharmaceutical

Biotechnology

Medical

2019

$9.3M

from 2 investors over 2 rounds

V

Vaxxinity raised $9.3M on April 7, 2022

Investors: CEPI (Coalition for Epidemic Preparedness Innovations)

V

Vaxxinity raised undisclosed on April 22, 2020

Investors: White Buffalo Capital